0208 GMT - The recovery trajectory for Malaysian casino operators is expected to remain robust, driven by rebounding travel demand and visa-free travel pacts between China, Malaysia and Singapore, Hong Leong IB analyst Chee Kok Siang says in a note. He highlights key developments to watch, including Resorts World New York City's bid for a New York casino license, with results expected in late 2025, and Genting Malaysia's potential entry into Thailand's Entertainment Complex. Hong Leong maintains an overweight rating on the gaming sector and pegs Genting as its preferred pick given its strong position to benefit from the recovery of its units Genting Singapore and Genting Malaysia, and potential gains if its associate TauRx Pharmaceuticals' hydromethylthionine mesylate drug secures an FDA approval. (yingxian.wong@wsj.com)
(END) Dow Jones Newswires
January 26, 2025 21:08 ET (02:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.